As the wave of in vivo CAR-T hype crests, Create Medicines is catching the swell with a $122 million series B meant to back its early pipeline of autoimmune and cancer candidates. Originally launched ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

Introducing the first in vivo data using RetroT, a first-in-class all-mRNA platform for stable gene delivery without viral components Demonstrating CREATE's leadership in in vivo immune cell ...

Zach began writing for CNET in November, 2021 after writing for a broadcast news station in his hometown, Cincinnati, for five years. You can usually find him reading and drinking coffee or watching a ...

[!INCLUDE [SQL Server Azure SQL Database Azure SQL Managed Instance Azure Synapse Analytics PDW FabricSQLDB](../../includes/applies-to-version/sql-asdb-asdbmi-asa-pdw ...

Early in my career, a colleague and I made a shared commitment one summer to eat healthier. Salads. Smoothies. The full routine. Like many well-intentioned plans, our discipline began to fade after a ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Dany Lepage discusses the architectural ...

Cell therapy company Link Cell Therapies is launching with $60 million and a mission to develop potent CAR-T therapies that go after a range of tumors while avoiding patients' healthy tissue. The ...

The T-Create P31 CinemaPr is specialized 10Gbps storage with mount points and hardware for attaching to video gear. It’s also rugged and performs very well for its class. Designed for videographers ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Ready to develop your first AWS Lambda function in Python? It really couldn’t be easier. The AWS ...

Journal Editorial Report: The Fed Chief signals rate cuts are coming. As we saw during the Covid pandemic, lab-created experiments can wreak havoc when they escape their confines. Once released, they ...

The Teamgroup C47 fell a bit shy of the competition in synthetic benchmarks, but was their equal in our real-world 48GB transfer tests and better than most during large sustained writes. PCIe 4.0 HMB ...